As researchers race against time the world over to roll out COVID-19 vaccine, Russia has now confirmed that the vaccine being developed by their team of scientists at Gamaleya National Research Center of Epidemiology and Microbiology has been successfully tested and production will begin from September.
In an interview with Russian news agency TASS, Russian Industry and Trade Minister Denis Manturov said Russia will manufacture several million doses of coronavirus vaccines per month by the beginning of next year.
“The Gamaleya Institute is working on serial production with three enterprises with facilities in the Vladimir, Yaroslavl and Moscow regions, those are Generium, R-Pharm and Binnopharm. We very much hope that serial production will start as early as in September,” he said.
Russia meanwhile also said it is in talks on production of coronavirus vaccine in other nations including Brazil and India.
Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev in an interview with Rossiya-24 TV channel said, “Our foreign partners express great interest in producing this vaccine in their countries. There is great interest from Brazil, from India, from many other countries that are very much looking forward to the Russian vaccine, the first vaccine in the world.”
Russia will manufacture several million doses of coronavirus vaccines per month by the beginning of next year, Russian Industry and Trade Minister Denis Manturov said in an interview with TASS agency.#RussianVaccine
— Russia in India (@RusEmbIndia) August 3, 2020
Earlier, chief of Russia’s sanitary watchdog Anna Popova had said she is confident the Russian vaccine against coronavirus will be absolutely safe and efficient. “I have no doubts that the vaccine [against the novel coronavirus] that is to reach people will be absolutely safe and, of course, efficient,” she said in an interview to a television channel.
Russian authorities are preparing a mass vaccination campaign against coronavirus from October, local news agencies reported, after a vaccine completed clinical trials. Doctors and teachers are likely to the first to be vaccinated.